HOWLWerewolf Therapeutics, Inc.
0.8735USD+113.41%Mkt Cap: 42.45M $P/E: —3d ago
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap42.45M $
Enterprise Value-1.03M $
Revenue (TTM)21.00M $
Gross Profit-5.18M $
Net Income (TTM)-60.82M $
Revenue/Share0.4390 USD
Last Price0.8735 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees39
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.44
PEG—
EV/EBITDA0.05
EV/Revenue-0.05
P/S1.00
P/B1.29
EPS (TTM)-0.77
EPS (Forward)-0.99
52W Range
0.270029% of range2.380
52W High2.380 USD
52W Low0.2700 USD
Profitability
Gross Margin-24.69%
Oper. Margin40.65%
EBITDA Margin-104.39%
Profit Margin-164.82%
ROE-245.20%
ROA-87.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-60.29M $
CapEx (TTM)—
FCF Margin-58.26%
FCF Yield-28.82%
Net Debt-21.99M $
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity1.52
Current Ratio2.91
Quick Ratio2.80
Book Value/Sh0.3350 USD
Cash/Share0.4520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+701.4%
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.48.60M
Float47.92M
Insiders1.40%
Institutions29.09%
Short Interest
Short Ratio1.2d
Short % Float2.74%
Short % Out.2.26%
Shares Short1.10M
Short (prev mo.)847.10K
Technical
SMA 500.3791 (+130.4%)
SMA 2000.6604 (+32.3%)
Beta0.29
S&P 52W Chg18.16%
Avg Vol (30d)10.27M
Avg Vol (10d)5.10M
Technical Indicators
RSI (14)84.5
MACD0.0397
MACD Signal0.0091
MACD Hist.+0.0305
BB Upper0.6514 USD
BB Middle0.4307 USD
BB Lower0.2100 USD
BB Width102.48%
ATR (14)0.0821 USD
Vol Ratio (20d)482.48x